[Modern magnetic resonance procedures for assessing tumor response]

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Magnetic resonance imaging (MRI) is crucial for cancer detection, characterization, and treatment monitoring.
• Quantifying tumor tissue changes and other surrogate parameters by MRI aids in assessing therapy response.
• Early monitoring of treatment success is vital due to increasing use of expensive, targeted cancer drugs.

Purpose of the Study:

• To review novel MR-based imaging approaches for assessing tumor response to targeted therapies.
• To emphasize the application of these techniques in evaluating anti-angiogenic and antivascular treatment effects.

Main Methods:

• Dynamic contrast-enhanced (DCE) and steady-state MRI for tumor perfusion and vessel permeability.
• Diffusion-weighted imaging (DWI) to measure tissue cellularity.
• Magnetic resonance spectroscopy (MRS) for monitoring metabolic changes.
• Emerging use of target-specific contrast agents for imaging apoptosis.

Main Results:

• MRI provides diverse surrogate parameters beyond simple metric changes for therapy response assessment.
• Advanced MRI techniques offer insights into tumor microenvironment and cellular dynamics.
• New contrast agents show potential for direct imaging of treatment-induced cellular events like apoptosis.

Conclusions:

• Novel MRI techniques offer comprehensive assessment of tumor response to targeted therapies.
• These advanced imaging methods are essential for early and accurate monitoring of anti-angiogenic and antivascular treatments.
• MRI plays a pivotal role in optimizing cancer treatment strategies and patient management.